We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

One Hour Preoperative Gatifloxacin

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00350363
First Posted: July 10, 2006
Last Update Posted: January 29, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Christopher Ta, Stanford University
  Purpose
Comparison of 1 day versus 1 hour application of topical Zymar.

Condition Intervention Phase
Ophthalmic Surgery Drug: Zymar Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single (Investigator)
Primary Purpose: Prevention
Official Title: One Hour Preoperative Gatifloxacin

Resource links provided by NLM:


Further study details as provided by Christopher Ta, Stanford University:

Primary Outcome Measures:
  • Number of Participant With Positive Culture [ Time Frame: 2 weeks ]

Enrollment: 60
Study Start Date: January 2007
Study Completion Date: December 2010
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1 hour gatifloxacin
presence of conjunctival bacteria 1 hour after administration of topical gatifloxacin
Drug: Zymar
zymar qid
Other Name: gatifloxacin

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • ophthalmic surgery

Exclusion Criteria:

  • taken antibiotics, allergic to fluoroquinolones
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00350363


Locations
United States, California
Stanford
Stanford, California, United States, 94304
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Christopher Ta, MD Stanford University
  More Information

Responsible Party: Christopher Ta, PI, Stanford University
ClinicalTrials.gov Identifier: NCT00350363     History of Changes
Other Study ID Numbers: 5004
First Submitted: July 5, 2006
First Posted: July 10, 2006
Results First Submitted: May 15, 2014
Results First Posted: January 29, 2015
Last Update Posted: January 29, 2015
Last Verified: January 2015

Additional relevant MeSH terms:
Gatifloxacin
Fluoroquinolones
Anti-Bacterial Agents
Anti-Infective Agents
Topoisomerase II Inhibitors
Topoisomerase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Nucleic Acid Synthesis Inhibitors